In this multicenter, placebo-controlled, double-blind trial, we randomly assigned women at imminent risk for delivery between 24 and 31 weeks of gestation to receive magnesium sulfate, administered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results